Skip to main content
Equibles
SBRA logo

SBRA · Sabra Health Care REIT, Inc. · Metrics

Track SBRA — free

Use SBRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SBRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.56 -0.04 (-0.20%) At close · Oct 23
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.00B
Shares
255.46M
Volume · Oct 23 1.83M Avg daily vol (3M) 2.4M

SBRA metrics

85 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$19.56
Market cap
$5.00B

Price action

20 metrics
Price change (1W)
+1.1%
Price change (30D)
-1.5%
Price change (3M)
-12.5%
Price change (6M)
-2.6%
Price change (YTD)
+3.3%
Price change (1Y)
+7.4%
Trailing year
Price change (5Y)
+30.1%
52-week high
$22.39
52-week low
$17.23
Change from 52-week high
-12.6%
Change from 52-week low
+13.5%
Annualized volatility
24.7%
Annualized volatility (3M)
21.3%
Beta
-0.2
RSI (14D)
51.2
Price vs SMA 50
-2.0%
Price vs SMA 200
-2.0%
Avg volume (3M)
2.40M
Relative volume
0.8
Average dollar volume
$48.39M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
255.46M

Valuation

14 metrics
P / FFO
19.2×
Company-stated · TTM · reciprocal yield 5.2%
P / AFFO
13.0×
Company-stated · TTM · reciprocal yield 7.7%
P / E (TTM)
75.2
Trailing earnings · reciprocal yield 1.3%
PEG ratio
—
EV / revenue
8.6×
reciprocal yield 11.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.8×
reciprocal yield 17.2%
P / book
1.8
reciprocal yield 55.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
13.4
reciprocal yield 7.4%
Earnings yield
1.3%

Historical valuation

8 metrics
P / E historical average (3Y)
61.6×
reciprocal yield 1.6%
P / E historical average (5Y)
61.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / revenue historical average (5Y)
9.2×
reciprocal yield 10.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
6.1%
Trailing 12 months
Payout ratio
455.5%
Shareholder yield
6.0%
Dividend / share (TTM)
$1.20
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
7.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$65.44M
Trailing 12 months
Diluted EPS (TTM)
$0.26
FCF margin
—
Effective tax rate
3.5%

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$3.42
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.26
Operating cash flow per diluted share (TTM)
$1.48
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$11.21

Growth

11 metrics
Revenue growth YoY
+24.7%
Year over year
Net income growth YoY
-138.5%
Revenue (TTM)
$859.56M
Trailing 12 months
EPS growth YoY
-137.0%
Shares change YoY
+4.7%
Year over year · more shares
Revenue CAGR (3Y)
+7.4%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-0.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.4%
Return on assets
1.2%
Debt / equity
1.0
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.39B
Latest balance sheet
Cash & equivalents
$231.58M
Total assets
$5.51B
Total debt
$2.63B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$371.57M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$13.13M
R&D / revenue
—
Stock compensation / revenue
1.5%

Ownership (13F)

9 metrics
13F filers
470
13F filer change QoQ
+6
Institutional ownership
102.2%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.6%
Holder tenure
15.2
Price vs estimated holder cost
+7.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
31.1%

Short interest

3 metrics
Short interest
7.8%
Latest settlement · 7.8 days to cover
Days to cover
7.8d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.17M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 99 filings 88 filers Visit website Investor relations